Low molecular weight heparin as an anticoagulant for in vitro platelet funtion studies
- 15 February 1990
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 57 (4) , 601-609
- https://doi.org/10.1016/0049-3848(90)90077-p
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Inhibition of platelet aggregation and [14C]serotonin release by luciferin: Luciferase preparationsThrombosis Research, 1986
- Zinc-induced platelet aggregation is mediated by the fibrinogen receptor and is not accompanied by release or by thromboxane synthesisBlood, 1985
- The use of prostacyclin in the separation from plasma and washing of human plateletsProstaglandins, 1982
- The Influence of Age, Sex, and the Use of Oral Contraceptives on the Inhibitory Effects of Endothelial Cells and PGI2 (Prostacyclin) on Platelet FunctionScandinavian Journal of Haematology, 1978
- Platelet Aggregation Following Heparin and Protamine AdministrationAnesthesiology, 1978
- Actions and Interactions of Antithrombin and HeparinNew England Journal of Medicine, 1975
- EFFECTS OF HEPARIN DERIVED FROM DIFFERENT TISSUES ON PLASMA-PHOSPHOLIPIDS AND PLATELET AGGREGATIONThe Lancet, 1973
- Heparin effects on plasma lysolecithin formation and platelet aggregationAtherosclerosis, 1973
- Adenosine Diphosphate‐induced Platelet Aggregation in Suspensions of Washed Rabbit PlateletsBritish Journal of Haematology, 1970
- Comparison of the effect of heparin and citrate on platelet aggregationJournal of Clinical Pathology, 1969